Detalhe da pesquisa
1.
High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin Lymphoma.
Ann Hematol
; 100(7): 1755-1767, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33625572
2.
Increased Efficacy of Stem Cell Chemomobilization with Intermediate-Dose Cytarabine Plus Granulocyte Colony-Stimulating Factor (G-CSF) Compared with G-CSF Alone in Patients with Multiple Myeloma: Results of a Randomized Trial.
Biol Blood Marrow Transplant
; 25(2): 248-255, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30266677
3.
Comparable safety profile of BeEAM (bendamustine, etoposide, cytarabine, melphalan) and BEAM (carmustine, etoposide, cytarabine, melphalan) as conditioning before autologous haematopoietic cell transplantation.
Contemp Oncol (Pozn)
; 22(2): 113-117, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30150889
4.
Increased efficacy of intermediate-dose cytarabine + G-CSF compared to DHAP + G-CSF for stem cell mobilization in patients with lymphoma: an analysis by the polish lymphoma research group.
Ann Hematol
; 95(2): 263-9, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26611854
5.
Correction to: High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin lymphoma.
Ann Hematol
; 100(7): 1919, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33760951
6.
Demographic, Hematologic, and Clinical Features of Myelodysplastic Syndrome Patients: Results from the First Polish Myelodysplastic Syndrome Registry.
Acta Haematol
; 134(2): 125-34, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25925777
7.
Narsoplimab, a Mannan-Binding Lectin-Associated Serine Protease-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem-Cell Transplantation-Associated Thrombotic Microangiopathy.
J Clin Oncol
; 40(22): 2447-2457, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35439028
8.
Tandem autologous hematopoietic cell transplantation with sequential use of total marrow irradiation and high-dose melphalan in multiple myeloma.
Bone Marrow Transplant
; 56(6): 1297-1304, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33339899
9.
Dermoscopy of Cutaneous Graft-Versus-Host-Disease in Patients After Allogeneic Hematopoietic Stem Cell Transplantation.
Dermatol Ther (Heidelb)
; 10(5): 1043-1061, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32676797
10.
Dermoscopic Evolution of Mycosis Fungoides After Allogeneic Hematopoietic Stem Cell Transplantation: a Case Series.
Dermatol Pract Concept
; 13(1)2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36892337
11.
Reduction of DMSO concentration in cryopreservation mixture from 10% to 7.5% and 5% has no impact on engraftment after autologous peripheral blood stem cell transplantation: results of a prospective, randomized study.
Bone Marrow Transplant
; 53(3): 274-280, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29269805
12.
The impact of blood donation on bone marrow harvest efficiency.
Bone Marrow Transplant
; 57(3): 507-509, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35042980
13.
Immunological properties of bone marrow microenvironment 1 year after allogeneic hematopoietic stem cell transplantation.
Exp Hematol
; 44(12): 1172-1180.e1, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27524270